Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Sarah Bly

Director, Regulatory Science, Strategy & Innovation
Worldwide Clinical Trials , United Kingdom

Sarah Bly, a highly motivated regulatory specialist with over 18 years of experience, is the Director of Regulatory Science, Stragegy and Innovation at Worldwide Clinical Trials, where she provides strategic senior-level direction and planning for the integration of advanced regulatory intelligence. Sarah drives implementation of short term and long term objectives for regulatory intelligence initiatives and oversees expert training ahead of new regulations. Sarah has a passion for sharing knowledge and a deep interest in supporting the improvement of guidance to the industry, specifically to improve the patient experience.
Sarah leads company initiatives for the successful implementation of the EU Clinical Trial Regulation 536/2014.

Disclosure information not submitted.

Presentation(s):